Joshua Budhu, Neuro-Oncologist at Memorial Sloan Kettering Cancer Center, shared a post on LinkedIn about a paper he co-authored:
“Excited to share our new paper in Journal of Neuro-Oncology:
‘Multidisciplinary review outperforms qualitative MR perfusion in distinguishing post-radiation brain metastasis recurrence versus radionecrosis.’
In a pathology-confirmed cohort of melanoma and NSCLC brain metastases at MSK, we found that multidisciplinary tumor board review meaningfully improves diagnostic performance when assessing post-SRS regrowing lesions.
Proud to have contributed alongside an incredible MSK team.”
Title: Multidisciplinary review outperforms qualitative MR perfusion in distinguishing post-radiation brain metastasis recurrence versus radionecrosis
Authors: Allison J. Toth, Stephanie M. Robert, Tara Fahy, Seamus Y. Wang, Matthew Wierzbicki, Stephen G. Bowden, Joshua A. Budhu, Luke R. G. Pike, James W. Smithy, Brandon S. Imber, Robert J. Young, Nelson S. Moss
You can read the full article in Journal of Neuro-Oncology.
More posts featuring Neuro-Oncology.